FMC vs NEM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
FMC Corporation is in a state of critical financial distress, evidenced by a Piotroski F-Score of 1/9 and a catastrophic 5-year price decline of 85.2%. While the stock appears cheap on a Price-to-Book (0.90) and Price-to-Sales (0.54) basis, these are classic 'value trap' indicators given the severe negative profit margin of -64.57% and an unsustainable dividend payout ratio of 223.08%. High leverage (Debt/Equity of 2.00) combined with declining revenue growth (-11.5% YoY) suggests significant operational instability.
Newmont Corporation presents a dichotomy between strong operational fundamentals and significant valuation premiums. While the Piotroski F-Score of 4/9 indicates stable health and the balance sheet is pristine with a Debt/Equity ratio of 0.17, the stock trades at a substantial premium to its Graham Number ($66.88) and Intrinsic Value ($44.73). Recent quarterly earnings beats are impressive, yet bearish insider sentiment and a 0/100 technical trend suggest a lack of immediate conviction from internal stakeholders and market momentum. The overall outlook is neutral as strong profitability is offset by overvaluation and negative insider signals.
Compare Another Pair
Related Comparisons
FMC vs NEM: Head-to-Head Comparison
This page compares FMC Corporation (FMC) and Newmont Corporation (NEM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.